Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD). Methods: PubMed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) of low-dose rivaroxaban in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Can, Kan, Yuanqing, Shi, Zhenyu, Guo, Daqiao, Fu, Weiguo, Li, Yanli, Lv, Qianzhou, Li, Xiaoyu, Si, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957832/
https://www.ncbi.nlm.nih.gov/pubmed/33732144
http://dx.doi.org/10.3389/fphar.2020.608247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957832/
https://www.ncbi.nlm.nih.gov/pubmed/33732144
http://dx.doi.org/10.3389/fphar.2020.608247

Ejemplares similares